Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation

Journal of Clinical Investigation

Volumn 114, Issue 9, 2004, Pages 1272-1280

  Yan, Fang ^a   John, Sutha K ^a   Wilson, Guinn ^a   Jones, David S ^a   Washington, M Kay ^a   Polk, D Brent ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KINASE SUPPRESSOR OF RAS 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CASP3 PROTEIN, MOUSE; CASPASE; CASPASE 3; CD31 ANTIGEN; KSR 1 PROTEIN KINASE; KSR-1 PROTEIN KINASE; ONCOPROTEIN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL FATE; CELL SURVIVAL; COLITIS; COLON MUCOSA; CYTOKINE PRODUCTION; ENTERITIS; IN VITRO STUDY; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL NUCLEUS; COLON; CYTOLOGY; EPITHELIUM CELL; GENETIC PREDISPOSITION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTESTINE; INTESTINE MUCOSA; METABOLISM; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; TIME; TRANSGENIC MOUSE; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD31; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; COLON; CYTOKINES; EPITHELIAL CELLS; GENETIC PREDISPOSITION TO DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; INFLAMMATION; INTESTINAL MUCOSA; INTESTINES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 15244361961     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421022     Document Type: Article

References (49)

1. Sartor, R.B. 2002. Mucosal immunology and mechanisms of gastrointestinal inflammation. In Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. M. Feldman, L.S. Friedman, and M.H. Sleisenger, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 21-51.
2. Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347:417-429.
3. Nilsen, E.M., et al. 1998. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology. 115:551-563.
4. Schmitz, H., et al. 2002. Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells. AIDS. 16:983-991.
5. Brown, G.R., et al. 1999. Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology. 116:593-601.
6. Hsueh, W., Caplan, M.S., Tan, X., MacKendrick, W., and Gonzalez-Crussi, F. 1998. Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective. Pediatr. Dev. Pathol. 1:2-16.
7. Kaiser, G.C., and Polk, D.B. 1997. Tumor necrosis factor α regulates proliferation in a mouse intestinal cell line. Gastroenterology. 112:1231-1240.
8. Corredor, J., et al. 2003. Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am. J. Physiol. Cell Physiol. 284:C953-C961.
9. Mizoguchi, E., et al. 2002. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology. 122:134-144.
10. Baker, S.J., and Reddy, E.P. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 12:1-9.
11. Warzocha, K., and Salles, G. 1998. The tumor necrosis factor signaling complex: choosing a path toward cell death or cell proliferation. Leuk. Lymphoma. 29:81-92.
12. Van, F., John, S.K., and Polk, D.B. 2001. Kinase suppressor of Ras determines survival of intestinal cells exposed to tumor necrosis factor. Cancer Res. 61:8668-8675.
13. Van, F., and Polk, D.B. 2002. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277:50959-50965.
14. Davis, R.J. 2000. Signal transduction by the JNK group of MAP kinases. Cell. 103:239-252.
15. Xia, Z., Dickens, M., Ramegeaud, J., Davis, R.J., and Greenberg, M.E. 1995. Opposing effects of ERK and JNK-p38 Map kinases on apoptosis. Science. 270:1326-1331.
16. Downward, J. 1998. Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8:49-54.
17. Troppmair, J., and Rapp, U.R. 2003. Raf and the road to cell survival: a tale of bad spells, ring bearers and decours. Biochem. Pharmacol. 66:1341-1345.
18. Van, F., and Polk, D.B. 2001. Kinase suppressor of Ras is necessary for tumor necrosis factor α activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res. 61:963-969.
19. Joseph, C.K., Byun, H.-S., Bittman, R., and Kolesnick, R.N. 1993. Substrate recognition by ceramide-activated protein kinase: evidence that kinase activity is proline-directed. J. Biol. Chem. 268:20002-20006.
20. Zhang, Y., et al. 1997. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell. 89:63-72.
21. Kornfeld, K., Horn, D.B., and Horvitz, H.R. 1995. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell. 83:903-913.
22. Therrien, M., et al. 1995. KSR, a novel protein kinase required for RAS signal transduction. Cell. 83:879-888.
23. Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D., and Therrien, M. 2002. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16:427-438.
24. Xing, H.R., and Kolesnick, R. 2001. Kinase suppressor of Ras signals through Thr269 of c-Raf-1. J. Biol. Chem. 276:9733-9741.
25. Nguyen, A., et al. 2002. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol. Cell. Biol. 22:3035-3045.
26. Lozano, J., et al. 2003. Deficiency of kinase suppressor of Ras 1 prevents oncogenic Ras signaling in mice. Cancer Res. 63:4232-4238.
27. Whitehead, R.H., VanEeden, P.E., Noble, M.D., Ataliotis, P., and Jat, P.S. 1993. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 90:587-591.
28. + TH1-like responses. J. Clin. Invest. 98:1010-1020.
29. Cacace, A.M., et al. 1999. Identification of constitutive and Ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol. Cell. Biol. 19:229-240.
30. Muller, J., Ory, S., Copeland, T., Piwnica-Worms, H., and Morrison, D.K. 2001. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol. Cell. 8:983-993.
31. Paris, F., et al. 2001. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 293:293-297.
32. Ishizuka, T., Takamizawa-Matsumoto, M., Suzuki, K., and Kurita, A. 1999. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor α-stimulated vascular endothelial cells. Eur. J. Pharmacol. 369:237-245.
33. Xing, H.R., Lozano, J., and Kolesnick, R. 2000. Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of Ras. J. Biol. Chem. 275:17276-17280.
34. Wang, X., and Studzinski, G.P. 2004. Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3. J. Cell. Physiol. 198:333-342.
35. Yu, W., Fantl, W.J., Harrowe, G., and Williams, L.T. 1997. Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr. Biol. 8:56-64.
36. Ohmachi, M., et al. 2002. C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation. Curr. Biol. 12:427-433.
37. Sundaram, M., and Han, M. 1995. The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction. Cell. 83:889-901.
38. Muller, J., Cacace, A.M., Lyons, W.E., McGill, C.B., and Morrison, D.K. 2000. Identification of B-KSR1, a novel brain-specific isoform of KSR1 that functions in neuronal signaling. Mol. Cell. Biol. 20:5529-5539.
39. Xing, H.R., et al. 2003. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat. Med. 9:1267-1268.
40. Chen, L.W., et al. 2003. The two faces of 1KK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9:575-581.
41. Pearson, G., Bumeister, R., Henry, D.O., Cobb, M.H., and White, M.A. 2000. Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation. J. Biol. Chem. 275:37303-37306.
42. van Kempen, L.C., and Coussens, L.M. 2002. MMP9 potentiates pulmonary metastasis formation. Cancer Cell. 2:251-252.
43. Myers, K.J., et al. 2003. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J. Pharmacol. Exp. Ther. 304:411-424.
44. Volle, D.J., et al. 1999. Phosphorylation of the kinase suppressor of Ras by associated kinases. Biochemistry. 38:5130-5137.
45. Ory, S., Zhou, M., Conrads, T.P., Veenstra, T.D., and Morrison, D.K. 2003. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13:1356-1364.
46. Sunnarborg, S.W., et al. 2002. Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277:12838-12845.
47. Cuthbert, A.P., et al. 2002. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 122:867-874.
48. Polk, D.B. 1994. Ontogenic regulation of PLCγ1 activity and expression in the rat small intestine. Gastroenterology. 107:109-116.
49. Kennedy, R.J., et al. 2000. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br. J. Surg. 87:1346-1351.